UAB Biofarmacijos tyrimų laboratorija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 0 |
| 0 |
| -108,876 |
| -108,876 |
| -31,650 |
| - |
| - |
| 50,216 |
| 119,442 |
| 94,426 |
| 75,232 |
| 2023 |
|---|
| 42,719 |
| 13,024 |
| -84,992 |
| -84,992 |
| -25,912 |
| -75.02 |
| -198.96 |
| -34,776 |
| 173,707 |
| 9,003 |
| 129,928 |
| 2024 |
|---|
| 0 |
| 0 |
| -59,263 |
| -59,263 |
| -52,445 |
| - |
| - |
| -94,040 |
| 96,697 |
| 21 |
| 2,636 |
Register and
explore Okredo data| 2024 |
|---|
| 0 |
| 0 |
| -59,263 |
| -59,263 |
| -52,445 |
| - |
| - |
| -94,040 |
| 96,697 |
| 21 |
| 2,636 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
-59,263 €30 % *
Net Profit (€)
-59,263 €30 % *
Profit per employee (€)
-52,445 €-102 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
-94,040 €-170 % *
Amounts Payable And Liabilities (€)
96,697 €-44 % *
Non-current Assets (€)
21 €-100 % *
CurrentAssets (€)
2,636 €-98 % *
